Opendata, web and dolomites
H2020 projects about "ovarian"
The page lists 35 projects related to the topic "ovarian".
| # | |||
|---|---|---|---|
| 1 | FORECEE | Female cancer prediction using cervical omics to individualise screening and prevention | 2015 |
| 2 | PRECEDE | PRECEDE: PancREatic Cancer Early DEtection | 2014 |
| 3 | MHAtriCell | Hyaluronan-rich matrices crosslinked with collagen-like peptides for 3D culture of ovarian cancer cells | 2015 |
| 4 | HGSOC | A novel approach into modeling origin and development of ovarian cancer | 2015 |
| 5 | MEDICIS-PROMED | MEDICIS-produced radioisotope beams for medicine | 2015 |
| 6 | HERCULES | Comprehensive characterization and effective combinatorial targeting of high-grade serous ovarian cancer via single-cell analysis | 2016 |
| 7 | EVI1inCancer | Overcoming the epigenetic and therapeutic barrier of EVI1-overexpressing cancers | 2016 |
| 8 | PRECIOUS | Scaling-up biodegradable nanomedicines for multimodal for multimodal precision cancer immunotherapy | 2016 |
| 9 | MechBiolRep | Mechanobiology of Bovine Reproduction | 2016 |
| 10 | SYNTRAIN | Targeting SYNthetic lethal interactions for new cancer treatments TRAINing network | 2016 |
| 11 | OvaRenew | OvaRenew as a first-line therapy in impaired egg quality treatment | 2016 |
| 12 | Curtana | Patented small molecule therapeutics that target cancer stem cells for the treatment of glioblastoma and other brain cancers | 2017 |
| 13 | DREMATURE | DNA repair mechanisms and therapy resistance of BRCA2-deficient cancers | 2018 |
| 14 | MOBER | Maternal Obesity and Epigenetic Reprogramming: from Gametogenesis to Early Embryonic Development | 2017 |
| 15 | DrugComb | Informatics approaches for the rational selection of personalized cancer drug combinations | 2017 |
| 16 | REPRODAMH | Extra-gonadal roles of Anti-Müllerian Hormone in the aetiology of polycystic ovary syndrome: the domino effect to reproductive neuroendocrine dysfunctions | 2017 |
| 17 | OVO-GROWTH | Oogenesis spotlighted: making mature human oocytes | 2017 |
| 18 | BRCA-ERC | Understanding cancer development in BRCA 1/2 mutation carriers for improved Early detection and Risk Control | 2017 |
| 19 | Ovage | OvAge: an innovative, user-friendly digital methodology that quantifies ovarian reserve by integratingclinical, biochemical and 3D-sonographic data to help decision-making in all phases of woman life | 2017 |
| 20 | CANCER-DC | Dissecting Regulatory Networks That Mediate Dendritic Cell Suppression | 2018 |
| 21 | INTACT | Imaging NM: A Nanoparticulate Precision Medicine Approach to Target Cancer | 2017 |
| 22 | VENUSCANCER | Women’s cancers: do variations in patterns of care explain the world-wide inequalities in survival and avoidable premature deaths? | 2018 |
| 23 | SEQURE | Targeted complete next-generation sequencing for companion diagnostics and personalized treatment of cancer | 2018 |
| 24 | HYPROTIN | Hyperpolarized Nuclear Magnetic Resonance Spectroscopy for Time-Resolved Monitoring of Interactions of Intrinsically Disordered Breast-Cancer Proteins | 2019 |
| 25 | FREIA | Female Reproductive toxicity of EDCs: a human evidence-based screening and Identification Approach | 2019 |
| 26 | RESIST3D | Targeting drug resistance in ovarian cancer through large-scale drug-response profiling in physiologically relevant cancer organoids | 2020 |
| 27 | EndoPos | Endosome positioning in tumour-stroma interactions | 2019 |
| 28 | CRISPR-KissCas9 | Challenging the KNDy Hypothesis Using CRISPR-Cas9 Genome Editing: Evaluation of the Role of Neurokinin B and Dynorphin in Kiss1 neurons in the Control of Fertility | 2020 |
| 29 | TargetDUBs | Targeting ubiquitin processing in cancer and fibrosis: novel probes for the Ubiquitin Carboxy-Terminal Hydrolases | 2019 |
| 30 | Anti-L1CAM | Anti-L1CAM antibody: A novel efficacious immunotherapy for pancreatic and ovarian cancer patients | 2019 |
| 31 | EARLYDETECT | Development of an accurate, early diagnostic tool for ovarian cancer | 2020 |
| 32 | PARPinhibit | A systems biology approach to tackle PARP-inhibitors resistance and identify novel therapeutic targets to overcome it | 2020 |
| 33 | BRCAstem | Monitoring cancer stem cell dynamics and therapeutic response in BRCA2-deficient breast tumour cells | 2020 |
| 34 | Tac1-Ovulation | Addressing the Roles of Tachykinins in the Control of Ovulation: Focus on the Substance-P/Tachykinin Receptor Type 1 (Tac1/Tacr1) System | 2020 |
| 35 | POMOLIM | Polycystic ovarian syndrome: novel molecular characterization and personalized in vitro maturation protocol. | 2020 |